SLC6A3 and Parkinson disease: On the neural side, high-resolution imaging of the dopaminergic system, such as the dopamine transporter (DAT) SPECT and PET with the usage of radiotracers, is emerging in the diagnosis and progression tracking of neurodegenerative diseases like Parkinson’s, dementias, Huntington’s, and others [67].